EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:

9 Months Ended

Dec. 31, 2019

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:

Earnings (Loss) Per Share

A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share is shown below (in thousands, except per share amounts): 

	For the three months ended				For the nine months ended
	December 31,				December 31,
	2019		2018		2019		2018
Basic earnings (loss) per share:
Net loss from continuing operations	$	(38,040)	$	(15,261)	$	(120,382)	$	(84,259)
Earnings from discontinued operations, net of tax	—		1,071,661		—		1,158,267
Net earnings (loss)	$	(38,040)	$	1,056,400	$	(120,382)	$	1,074,008
Basic weighted-average shares outstanding	67,473		77,398		68,021		77,260
Continuing operations	$	(0.56)	$	(0.20)	$	(1.77)	$	(1.09)
Discontinued operations	—		13.85		—		14.99
Basic earnings (loss) per share	$	(0.56)	$	13.65	$	(1.77)	$	13.90
Diluted earnings (loss) per share:
Basic weighted-average shares outstanding	67,473		77,398		68,021		77,260
Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method	—		—		—		—
Diluted weighted-average shares outstanding	67,473		77,398		68,021		77,260
Continuing operations	$	(0.56)	$	(0.20)	$	(1.77)	$	(1.09)
Discontinued operations	—		13.85		—		14.99
Diluted earnings (loss) per share	$	(0.56)	$	13.65	$	(1.77)	$	13.90

Due to the net loss from continuing operations during the three and nine months ended December 31, 2019 and 2018, the dilutive effect of options, warrants, and restricted stock units was excluded from the diluted loss per share calculation since the impact on the calculation was anti-dilutive. These anti-dilutive units are shown below (shares in thousands):

	For the three months ended		For the nine months ended
	December 31,		December 31,
	2019	2018	2019	2018
Number of shares outstanding under options, warrants and restricted stock units plans	2,483	3,276	2,551	3,458

Restricted stock units that were outstanding during the periods presented but were not included in the computation of diluted loss per share because the effect was anti-dilutive are shown below (shares in thousands): 

	For the three months ended		For the nine months ended
	December 31,		December 31,
	2019	2018	2019	2018
Number of shares outstanding under restricted stock units plans	961	22	732	235

Stockholders’ Equity

Under the modified common stock repurchase program, the Company may purchase up to $1.0 billion of its common stock through the period ending December 31, 2020. During the nine months ended December 31, 2019, the Company repurchased 2.6 million shares of its common stock for $121.2 million under the stock repurchase program.  Through December 31, 2019, the Company had repurchased a total of 25.1 million shares of its stock for $570.2 million under the stock repurchase program, leaving remaining capacity of $429.8 million.

Accumulated other comprehensive income balances of $6.8 million and $7.8 million at December 31, 2019 and March 31, 2019, respectively, reflect accumulated foreign currency translation adjustments.